Safety and immunogenicity of the anti-cocaine vaccine UFMG-VAC-V4N2 in a non-human primate modelBrian Sabato, Fréderico Duarte Garcia, Sordaini M. Caligiorne et al.|Vaccine|2023Cited by 7
Low doses of pharmaceutical formulations loaded with UFMG-V4N2 immunogen induce the production of IgG anti-cocaine antibodies and provide evidence of cerebral protection in the preclinical modelBruna Rodrigues Dias Assis, Gisele Assis Castro Goulart, Paulo Sérgio de Almeida Augusto et al.|JCIS Open|2023Cited by 1